Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.
Nature Medicine2000Vol. 6(9), pp. 951–955
Citations Over TimeTop 10% of 2000 papers
Related Papers
- → The changing face of HIV vaccine research(2012)53 cited
- → V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers(2019)34 cited
- → Current views on the potential for development of a HIV vaccine(2017)27 cited
- → HIV-1 Prophylactic Vaccine Trials in Thailand(2005)23 cited
- → Boosting with ALVAC-HIV and AIDSVAX B/E enhances Env constant region 1 and 2 antibody-dependent cellular cytotoxicity(2019)3 cited